between peroxisome proliferator-induced changes in Leydig cell function and the development of Leydig cell tumors, c 1996 soday of Toxicology A structurally diverse group of chemicals has been identified which induces peroxisomes in the liver of treated rats and increases the incidence of hepatocellular carcinoma (reviewed in Gibson and Lake, 1993) . A review of the literature shows that some peroxisome proliferators also increase the incidence of Leydig cell tumors in rats: clofibrate (Physicians' Desk Reference, 1994) , ammonium perfluorooctanoate 3 (Sibinski, 1987) , trichloroethylene (World Health Organization, 1985; Mennear, 1988) , gemfibrozil (Fitzgerald et al, 1981) , and Wyeth 14,643 (Cook et al., 1994) . However, chemical induction of this tumor type may have gone undetected in carcinogenicity studies for many peroxisome proliferators owing to the use of Fischer rats, which have a spontaneous incidence of virtually 100% Leydig cell tumors by 2 years of age (Turek and Desjardins, 1979) . It is therefore proposed that peroxisome proliferators, as a class of compounds, may increase the incidence of Leydig cell tumors in rats.
In general, peroxisome proliferators lack direct genotoxicity, covalent binding to DNA, and mutagenicity (reviewed in Nilsson et al., 1991; Bentley et ai, 1993) , and their carcinogenicities are therefore generally attributed to a nongenotoxic mechanism (reviewed in Grasso and Hinton, 1991) . As such, much attention has been focused on carcinogens which modify the endocrine system to affect hormone-responsive organs such as the testis (Neumann, 1991) . The major endocrine control of Leydig cells is regulated by feedback loops which exist between the hypothalamus, adenohypophysis, and the testes. Briefly, hypothalamic gonadotropin-releasing hormone stimulates luteinizing hormone (LH) release from the adenohypophysis, which stimulates Leydig cells to produce androgens, which in turn reduce LH release from the adenohypophysis.
Increased circulating concentrations of LH have been associated with increased incidences of hyperplasia and tumors of the Leydig cell. Elevated levels of LH can be achieved by various means. For example, Leydig cell hyperplasia is reported following 5 weeks of treatment with human chorionic gonadotrophin (hCG) in adult Sprague-Dawley rats (Christensen and Peacock, 1980) and 16 weeks of hCG treatment in human volunteers (Heller and Leach, 1971) . Since LH and hCG act through the same receptor to stimulate Leydig cells, this suggests that sustained increases in serum LH may also produce Leydig cell hyperplasia, which could lead to tumor formation. There are also conditions where the androgen receptor is defective, as in Imperato-McGinley syndrome (Imperato-McGinley and Peterson, 1976) , or where the receptor is pharmacologically blocked by an antiandrogen, such as fiutamide (Simard et al., 1986) . Hyperplasia and tumors of the Leydig cell result in both instances, due to hypersecretion of LH because the hypothalamus and adenohypophysis, normally under negative feedback by androgens, fail to be inhibited by androgens. These examples illustrate how alterations in parts of the hypothalamic-adenohypophyseal-testicular axis can upset the normal feedback system, a situation leading to sustained elevations in serum LH, which may be involved in Leydig cell tumorigenesis.
A diet of 300 ppm of the peroxisome proliferator ammonium perfluorooctanoate (C8) for 2 years increased the incidence of Leydig cell adenomas in Crl:CDBR (CD) rats 3 (Sibinski, 1987) . However, C8 treatment did not affect serum LH in a subsequent 14-day gavage study, but dose-dependently reduced serum testosterone and increased estradiol (Cook et al., 1992) . Furthermore, the lesion produced by C8 appeared to be at the testicular level rather than at the level of the hypothalamus or adenohypophysis (Cook et al., 1992) and was later confirmed in vitro using cultured rat Leydig cells (Biegel et al., 1995) . This indicated that C8 has a direct action to modify the function of Leydig cells. There is no information as to whether all peroxisome proliferators produce hormonal changes similar to C8, but it is interesting that clofibrate (Rao et al., 1994) , Wyeth 14,643 (Cook et al., 1994) , and di(2-ethylhexyl) phthalate (Eagon et al., 1994a,b) are reported to increase the serum concentration of estradiol in rats. It is not known whether this response is due to a direct action on Leydig cells or whether the increase in estradiol is important in Leydig cell tumorigenesis.
Using C8 as our prototype compound, a hypothesis was proposed that peroxisome proliferators directly affect rat Leydig cell function by some, as yet undetermined, mechanism which participates in Leydig cell tumorigenesis. By measuring steroidogenesis as a marker of Leydig cell function, we evaluated whether the following 11 peroxisome proliferators share a common effect on rat Leydig cells in vitro: 2,4-dichlorophenoxyacetic acid (2,4-D), acetylsalicylic acid (ASA), C8, ciprofibrate (CIP), clofibric acid (CLOF), gemfibrozil (GEM), tiadenol (TIAD), tibric acid (TIB), trichloroacetic acid (TCA), trichloroethylene (TCE), and Wyeth 14,643 (WY).
MATERIALS AND METHODS

Materials.
The following compounds were obtained for these studies: tibric acid (2-chloro-5-(3,5-dimethylpiperidinosulphonyl) Tibric acid and WY were dissolved in dimethyl sulfoxide, and C8 was dissolved in deionized water. The remaining test compounds were dissolved in absolute ethanol. Stock solutions of all test compounds were prepared in the appropriate vehicle, from which a l-in-200 dilution was made in RPMI culture medium (see below for composition of medium).
Animals.
Male CD rats were raised to adulthood (12-16 weeks of age) at Haskell Laboratory, DuPont, from a stock of animals purchased from Charles River Breeding Laboratories (Raleigh, NC). The rats were weaned at 3 weeks of age, caged individually, and provided unlimited access to tap water and Purina Certified Rodent Chow No. 5002 meal (Ralston Purina, St. Louis, MO). Animal rooms were illuminated by fluorescent light on a 12-hr light/dark cycle and maintained at a temperature of 23 ± 2°C and a relative humidity of 50 ± 10%.
Leydig cell isolation. Leydig cells were prepared and isolated from adult CD rats by collagenase dispersion followed by Percoll gradient purification (Biegel el al., 1993) . The cells were maintained in a culture medium of phenol red-free RPMI medium containing 10% (v/v) fetal calf serum, 2 mM L-glutamine, 100 units/ml penicillin, 100 /ig/ml streptomycin, and 0.25 /ig/ml amphotericin B. Cell viability was in excess of 95%, as determined by trypan blue exclusion, and Leydig cell purity was 82%, as determined by 3/J-hydroxysteroid dehydrogenase histochemistry (Payne and Sha, 1993) Study design. Cells were seeded into 24-well culture plates (Corning, Coming, NY) at a density of 50,000 cells/500 /xl culture medium/well. The cells were incubated for 1-hr at 37°C in a humidified atmosphere of 5% CO 2 :2% O 2 :93% N 2 before replacing the medium with 500 /J! fresh culture medium containing different concentrations of test compound. With the exception of TCE, all compounds were used as their active metabolite. After a further incubation of 21 hr, the culture medium was retrieved and stored at -60°C for later assay of estradiol. The exposure of the cells to the test compound was continued for an additional 3 hr in 500 /JI fresh culture medium, in the presence or absence of 2 IU human chorionic gonadotropin (Wyeth-Ayerst Labs., Paoli, PA). The medium collected al this time point was stored at -60°C for later assay of testosterone. The medium was replaced daily for longer term culture of Leydig cells.
Radioimmunoassay.
The concentrations of estradiol and testosterone were measured by radioimmunoassay (Diagnostic Products Corporation, Leydig cells were plated at a density of 50,000 cells/well and treated with WY for 21 hr. The medium was then collected for estradiol assay and replaced with fresh WY-containing medium ± 2 IU hCG. The release of testosterone was measured after 3 hr. Cell viability was determined by trypan blue exclusion Data are presented as means ± SEM.
* Significantly different from control {p =s 0.05, n = 3 wells/treatment). c Not determined due to major loss of cells from cultures.
Los Angeles, CA). The intra-and interassay coefficients of variation were <IO and <15%, respectively.
Data analysis. The studies on the 11 compounds were conducted over four experiments. To correct for interexpenment differences in the baseline responses, the results are expressed as mean percentages of the respective control responses and, where indicated, the standard error of the mean Data were analyzed by a one-way analysis of variance. When the corresponding F test for differences among test groups was significant, pairwise comparisons were made with the Dunnett's test (p « 0.05).
The concentration of peroxisome proliferator which produced a halfmaximum response on Leydig cell function was estimated using ORIGIN (MicroCal Software, Inc., Northampton, MA). Although most peroxisome proliferators were used at near-cytotoxic doses, a maximum response was not always clearly established. Consequently, for the purposes of this calculation, it was assumed that a maximum response was achieved.
RESULTS
The effect of WY on Leydig cell function is summarized in Table 1 and is representative of the endpoints measured for the other compounds used in these studies. Higher concentrations of WY depleted the number of cells in the cultures and were associated with marked decreases in testosterone, but only a small decrease in estradiol production. Data were expressed as percentages of the control responses to correct for interexperiment variation in the baseline responses. With the exception of WY (Table 1) , data obtained at cell-depleting or cytotoxic concentrations of peroxisome proliferators, as determined by trypan blue exclusion, are not shown. ASA, CLOF, and TCE were noncytotoxic at the highest concentration of 5000 \IM used in these studies.
With the exception of 2,4-D, which reduced the testosterone response to 70% of control (not statistically significant), treatment of Leydig cells with peroxisome proliferators for 24 hr significantly reduced (p =s 0.05) the hCG-stimulated release of testosterone in a dose-dependent fashion (Fig. 1) . None of the compounds significantly increased the testosterone response. The estimated concentrations of compounds which decreased the response to 50% of control, IC50, are shown in Table 2 . With the exception of 2,4-D, CIP, and TCE, which had no effect on the baseline release of testosterone, all compounds significantly reduced (p =£ 0.05) the nonstimulated release of testosterone (Fig. 2) .
With the exception of C8, GEM, and TIAD, which reduced the basal release of estradiol (p =e 0.05), all other peroxisome proliferators increased the production of estradiol by Leydig cells (p =e 0.05; Fig. 3 ). The estimated concentrations of compounds which increased the response to 50% of maximum, EC50, are shown in Table 2 . A previous study with C8 indicated that a more prolonged exposure time was required to produce a stimulatory effect on estradiol release from rat Leydig cells in vitro (Biegel et ai, 1995) . Leydig cells were therefore treated with C8, GEM, or TIAD for up to 3 days. The release of estradiol was found to be increased by C8 and TIAD after 2 days of treatment, and also after 3 days for C8 (Fig. 4) . Cytotoxicity, as determined by trypan blue exclusion, was evident in the cells exposed to TIAD for 3 days. The inhibitory effect of GEM on estradiol seen after 1 day of treatment persisted for up to 3 days (Fig. 4) .
DISCUSSION
The majority of peroxisome proliferators have been demonstrated to induce liver tumors in rats, and some also pro- " IC50 represents the estimated concentration of compound which reduced the response to 50% of the control response.
* Except where indicated,' EC50 represents the estimated concentration of compound which increased the control response to half-maximum.
' Plasma concentration of compound achieved in rats dosed in diet studies. Refer to citation for study details.
' Grizzle et al., 1995 . ' EC50 was not calculated because compound reduced the release of estradiol.
! Unpublished report by the 3M Company, Report No. HWI 6329-100. 'Paul et al., 1994 . 'Buchanan et al., 1995 . duce Leydig cell tumors (see Introduction). Our data indicate that peroxisome proliferators directly alter Leydig cell function in vitro, which provides a possible mechanism for Leydig cell tumorigenesis by these few compounds. Therefore, a potential exists that this relationship also applies to other peroxisome proliferators shown to alter Leydig cell function. Table 2 compares the rat plasma concentrations of peroxisome proliferators during dietary studies, where information was available, with the calculated IC50 and EC50 values for each compound on testosterone and estradiol production. The changes in Leydig cell function occurred at concentrations similar to those achieved in plasma and at dose levels known to produce Leydig cell tumors. It is therefore possible that compounds which produce hepatic peroxisome proliferation also alter Leydig cell function in vivo and produce Leydig cell tumors.
There is some evidence in CD rats that, compared with the liver and pancreas, Leydig cells are more sensitive and the tumors develop more quickly to the peroxisome proliferators HCFC-123 (l,l-dichloro-2,2,2-trifluoroethane; Malley et al., 1995) and GEM (Fitzgerald et al., 1981) . However, compared with the effective peroxisome proliferator concentrations on Leydig cell function ( Fig. 1 and Table 2 ), lower concentrations have been reported to increase hepatocyte peroxisomal /3-oxidation (Bars et al., 1993; Foxworthy and Eacho, 1986; Kocarek and Feller, 1989) , cytochromes P450 2B1 and 4A1 (Bars et al., 1993; Kocarek and Feller, 1989) , and carnitine acetyltransferase and 7-ethoxycoumarin O-deethylase (Gray et al., 1982) . Many reasons could account for the difference in sensitivity of Leydig cells and hepatocytes to peroxisome proliferators in vitro, including differences in pharmacokinetic handling of the compound by the cells and different mechanisms of action.
The finding that peroxisome proliferators generally reduced both the hCG-stimulated and the baseline release of testosterone from Leydig cells in vitro suggests that these compounds would reduce the plasma concentration of testosterone in vivo. Of the information available on peroxisome proliferators, only a 14-day rat study with C8 has been reported to reduce the concentrations of testosterone in serum and testicular interstitial fluid, which was not accompanied by an increase in LH (Cook et al., 1992) . Such an increase would have been anticipated through a reduction in androgen inhibitory feedback on the hypothalamus and adenohypophysis. However in a 2-year dietary study, serum testosterone and LH were not affected by C8 or WY, but the serum concentration of estradiol increased twofold (Cook et al., 1994) .
In contrast to the general inhibitory effect of peroxisome proliferators on testosterone production, the basal release of estradiol was generally increased, suggesting that these compounds do not merely produce an overall depression of Leydig cell function, but rather exert specificity in their actions. A previous study in rat Leydig cells showed that C8 treatment for up to 12 hr reduced estradiol production, followed by increased estradiol release after 48 hr (Biegel et al., 1995) . This biphasic effect of C8 was confirmed in the present time-course study and also demonstrated for TIAD after 2 days of treatment (Fig. 4) . Unpublished data from our laboratory also show that, in addition to C8 and TIAD, seven other peroxisome proliferators produced a greater increase in estradiol release after 2 or 3 days of treatment than after 1 day. Therefore, it is possible that the effect of peroxisome proliferators, as a class, on estradiol release generally comprises an initial inhibition and a later stimulation. This biphasic type of response is consistent with enzyme induction. Aromatase (cytochrome P450 19A1) catalyzes the conversion of testosterone to estradiol. We have previously reported induction of liver but not testicular aromatase activity in C8-treated rats (Biegel et al., 1995) , and the serum concentration of estradiol is directly proportional to the total hepatic aromatase activity (Liu et al., 1996) . The inability to detect a change in testicular aromatase activity was attributed to intervention by endocrine and paracrine feedback mechanisms to normalize the function of Leydig cells in vivo or because the measurements of aromatase activity were made from whole testes, rather than from purified Leydig cells.
The increase in estradiol production by C8-treated Leydig cells in vitro is interesting because, in addition to C8, the peroxisome proliferators di(2-ethylhexyl)phthalate (DEHP), clofibrate, and WY (Cook el ai, 1994; Eagon et al., 1994a,b; Rao et al., 1994 ) also increase serum estradiol in rats. However, rather than through a testicular effect, Eagon and coworkers (1994a,b; Rao et al., 1994) report that the increased serum estradiol produced by DEHP and clofibrate is associated with reduced activities of the hepatic estrogen-metabolizing enzymes estrogen 2-hydroxylase and estrogen sulfotransferase. The significance of elevated serum estradiol and its physiological importance is not known.
Peroxisome proliferators were found to alter Leydig cell steroidogenesis, but this endpoint may indicate changes in other Leydig cell functions. For example, in addition to testosterone, Leydig cells also secrete bioactive substances which participate in the paracrine control of spermatogenesis (reviewed in Skinner, 1991) . Disturbances in this regulation would be expected to affect spermatogenesis. In this respect, some hepatic peroxisome proliferators which produce Leydig cell tumors also affect spermatogenesis and/or fertility. Clofibrate arrests spermatogenesis in dogs and monkeys (Physicians' Desk Reference, 1994) , and gemfibrozil dosedependently reduces male fertility in rats (Physicians ' Desk Reference, 1994) . HCFC-133a (1,1,1 -fiuoro-2-chloroethane) has been shown to produce hepatic peroxisome proliferation in rats (personal communication from Dr. D. A. Keller, Haskell Laboratory, DuPont), Leydig cell tumors, arrest of spermatogenesis, and seminiferous tubule atrophy (Longstaff et al., 1984) . Although not evaluated for effects on fertility, trichloroethylene produces sperm head abnormalities in mice (Land et al, 1981) but not in rats (World Health Organization, 1985) . The mechanisms of peroxisome proliferatorinduced disruption of spermatogenesis and fertility are unknown, but may involve changes in Leydig cell steroidogenesis and their paracrine functions, a condition which might lead to Leydig cell hyperplasia and tumors.
The present study showed that those peroxisome proliferators demonstrated to produce Leydig cell tumors in rats also directly modify Leydig cell steroidogenesis in vitro. Other peroxisome proliferators were also shown to change Leydig cell function, suggestive of a possible association. The mechanism underlying this Leydig cell effect is not known, but it is clear that further investigations are necessary to address this and to clarify the apparent relationship between peroxisome proliferator-induced changes in Leydig cell function in vitro and the development of Leydig cell tumors in vivo.
